MOVELAT
A SIMPLER ALTERNATIVE TO OTHER TOPICAL NSAIDs
What is Movelat?
Movelat is a topical non-steroidal anti-inflammatory drug (NSAID), indicated for the symptomatic relief of muscular pain and stiffness, sprains and strains and pain due to rheumatic and non-serious arthritic conditions. 1
An appropriate first line topical NSAID treatment in accordance with NICE guidelines on osteoarthritis; Movelat’s unique 2-step mode of action works in a clinically proven way to provide fast, effective relief from joint pain and inflammation. 2, 3, 4
Movelat contains two active ingredients – salicylic acid and Mucopolysaccharide Polysulphate (MPS), which help deliver anti- inflammatory and analgesic action deep within the tissue. 1, 2, 3
Movelat Cream and Gel are available on prescription in a 125g tube.
Movelat Relief Cream and Relief Gel are stocked by pharmacies nationwide.
Movelat is not your typical topical.
| Movelat Cream/Gel 3 |
Voltarol Emulgel 5 |
Ibuprofen Gel 9 |
Piroxicam Gel 10 |
|
|---|---|---|---|---|
| Number of active ingredients | 2 | 1 | 1 | 1 |
| Suitable for use alongside oral NSAIDs | ✔ | ✘ | ✘ | ✘ |
| Suitable for long term use – without the need for review | ✔ | ✘ | ✘ | ✘ |
| Reduced risk of GI side effects | ✔ | ✘ | ✘ | ✘ |
Why Movelat?
Unlike other topical NSAIDs:
Movelat can be used alone or safely alongside oral NSAIDs without an increase in the risk of untoward systemic side effects and; 3
Movelat can be used long-term without the need for review. 3
Usage instructions for other topical NSAIDs in the UK including Voltarol, Ibuprofen Gel and Piroxicam Gel:
Caution the concomitant use of oral and topical NSAIDs for fear of increasing untoward systemic side effects. 5
Recommend that therapy be reviewed anywhere between 2-4 weeks. 5
Proven clinical efficacy
Movelat is clinically proven to provide fast, effective relief from joint pain and inflammation, 2, 3, 4 such as in osteoarthritis; which interferes with the normal activities of more than 30% of over-50s in the UK. 8
Studies have shown that Movelat has reduced pain on movement by 28% with no adverse events reported. 2
